SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-06-001588
Filing Date
2006-03-14
Accepted
2006-03-14 16:26:24
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 OXIGENE, INC. b58436oie10vk.htm 10-K 741140
2 EX-10.29 FORM OF INCENTIVE STOCK OPTION AGREEMENT b58436oiexv10w29.htm EX-10.29 53288
3 EX-10.30 FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT b58436oiexv10w30.htm EX-10.30 50873
4 EX-10.31 FORM OF RESTRICTED STOCK AGREEMENT b58436oiexv10w31.htm EX-10.31 51774
5 EX-23 CONSENT OF ERNST & YOUNG LLP. b58436oiexv23.htm EX-23 2036
6 EX-31.1 CERTIFICATION OF CEO b58436oiexv31w1.htm EX-31.1 6864
7 EX-31.2 CERTIFICATION OF CFO b58436oiexv31w2.htm EX-31.2 6539
8 EX-32 CERTIFICATION OF CEO & CFO PURSUANT TO SECTION 906 b58436oiexv32.htm EX-32 3491
  Complete submission text file 0000950135-06-001588.txt   917296
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21990 | Film No.: 06685378
SIC: 2836 Biological Products, (No Diagnostic Substances)